A buoyant stock market, cheaper pump prices, and the housing revival are trumping the worrisome negatives
Cheaper Asian imports and economic disaster in Europe has made U.S. manufacturing soft
Sounds like Watergate was a lot of fun. No wonder Washington's old hands can't help but reminisce
Almost 80 percent of the U.S. military's mobile devices are BlackBerry products, but now that will probably change
A government crackdown on foreign investment has sent speculators fleeing, but one man is more bullish than ever
Quit-smoking apps get hot in a $1 billion market
On a new reality TV show, first prize is a fast-food outlet. Winners, beware
For some, Joel Peterson says, online courses or specialized one-year programs may be better choices than the MBA
Bitcoin crashed last month. That hasn't stopped venture capital firms from investing in Bitcoin companies
San Mateo, Calif.
Founders: Dr. Michael Selley, Dr. Lawrence Steinman, and Dr. Marc Feldmann
VC Investment over the last four quarters: $27 million
Founded in Australia in 2005 and established in the U.S. in 2007, Nuon Therapeutics is a clinical stage company developing oral treatments for multiple sclerosis and rheumatoid arthritis. The six-employee firm, which had previously raised a $5 million Series A round, is continuing development while conserving cash during the downturn, says CEO Rodney Pearlman. "Since we are in clinical stage development, this can be an expensive phase, so we have to ensure we meet our goals while being fiscally responsive to the current environment," he says.
Key to startup success: "Be opportunistic and think outside the box."